PTEN and neoplasm: As low PTEN protein patient tumours displayed a PI3K‐AKT substrate phosphorylation activation signature (Fig 1I), we examined the requirement for PI3K‐AKT signalling in the hyperprotrusive PTEN KO phenotype.